Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

39 results about "Antigen test" patented technology

In an antibody assay, the sample is taken and mixed with a material containing an antigen. Lab tests can be run on blood and urine samples to check for antibodies. Since antigens react to antibodies, specific antibodies can be used to test for the presence of infectious organisms.

Fluorescent microsphere immunochromatographic testing card for testing five indexes of hepatitis b and method for preparing same

The invention discloses a fluorescent microsphere immunochromatographic testing card for testing five indexes of hepatitis b and a method for preparing the same. The testing card comprises a hepatitis b surface antigen test paper strip, a hepatitis b e surface antigen test paper strip, a hepatitis b surface antibody test paper strip, a hepatitis b e surface antibody test paper strip, and a hepatitis b core antibody test paper strip. Each test paper strip is formed by overlapping and bonding filter paper, a sample pad, a glass fiber film spray-coated with fluorescent microspheres, a cellulose nitrate film and water absorption paper on a bottom plate by glue in sequence, wherein the cellulose nitrate film is coated with antigens serving as a testing area and anti-rabbit antibodies serving as a quality control area; and during a test, after emitted fluorescent light passes a filter, the emitted spectrum is collected, accumulated and multiplied by the CCD scanning technology and then converted into a numerical signal, the numerical signal is multiplied by a correction factor, and the strength of the corrected fluorescent light is substituted in a standard curve of a fluorescence analyzer, so that the concentrations of the five indexes of hepatitis b of the sample can be automatically worked out. The test of hepatitis b viruses by the testing card has the characteristics of specificity, sensitivity, simpleness and accuracy.
Owner:WUXI ZODOLABS BIOTECH

Visible protein chip for detecting poultry disease serum antibody, its preparation method and application

The invention discloses a visual protein chip for detecting serum antibody of new-castle disease virus of chickens, infectious bronchitis virus of chickens, avian influenza virus and infectious bursal disease virus of chickens , which is prepared by the following steps: purifying and diluting whole proteins of the four virus respectively; pointing samples of the positive control serum, the negative control serum and the four virus proteins onto a chip carrier respectively; drying, fixing, sealing and washing the samples to obtain the visual protein chip. The visual protein chip uses the purified whole proteins as capturing antigens to detect the virus-specific antibodies in chicken serum so as to simplify the preparation technology and reduce the production cost, and the visual protein chip has better specificity but no cross, has high reliability of results and has the advantages of quickness, simplicity and convenience, high sensitivity, good specificity and the like. When the serum is diluted by 6,400 times, the visual protein chip still can detect the antibodies, the sensitivity is 400 times of that of the prior AGP detection method. According to the detection to serum samples in-place, the detection rate of the visual protein chip is higher than the proir AGP method remarkably.
Owner:HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI

Three-in-one colloidal gold chromatographic test strip for detecting thiamphenicol, chloramphenicol and florfenicol and preparation method thereof

The invention provides a three-in-one colloidal gold chromatographic test strip for detecting thiamphenicol, chloramphenicol and florfenicol and a preparation method thereof, and belongs to the technical field of immunological detection. The preparation method comprises two parts, namely, the preparation of a monoclonal antibody and the preparation of a colloidal gold chromatographic test strip, wherein the monoclonal antibody can be used for recognizing thiamphenicol, chloramphenicol and florfenicol at the same time and is high in sensitivity; the colloidal gold chromatographic test strip comprises a polyvinyl chloride backing; a sample pad is arranged at the front end of the polyvinyl chloride backing and is connected with the front end of a nitrocellulose membrane; the rear end of the nitrocellulose membrane is connected with a water absorbing pad; the monoclonal antibody marked by colloidal gold is used as a combining pad; the nitrocellulose membrane is sequentially wrapped with a chloramphenicol sodium succinate-BSA (Bovine Serum Albumin) antigen test ray T and a goat-anti-mouse IgG control ray C. The three-in-one colloidal gold chromatographic test strip for detecting thiamphenicol, chloramphenicol and florfenicol is fast to detect, and the detection needs only 3 to 5 minutes; the test strip is convenient to carry, and suitable for detection on site; the operation is simple and convenient and does not need a professional technical person.
Owner:JIANGNAN UNIV

Reagent kit for detecting antiuninuclear cell proliferation Listeria bacteria by colloidal gold Hly gene monoclonal antibodies

The invention relates to a reagent kit for detecting antiuninuclear cell proliferation Listeria bacteria by colloidal gold Hly gene monoclonal antibodies and belongs to the technical field of hygiene inspection and medical inspection. The reagent kit is characterized by comprising the steps of: 1, primer design; 2, polymerase chain reaction (PCR) amplification; 3, agarose gel electrophoresis reaction conditions; 4, target deoxyribonucleic acid (DNA) segment cutting; 5, heat shock conversion method application; 6, reagent kit purification and plasmid preparation by a sodium dodecyl sulfate (SDS) cracking method; 7, protein induction expression; 8, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE); 9, required strip cutting from the SDS-PAGE; and 10, colloidal gold preparation. The regent kit has the beneficial effect that the limitation aiming at the single-clostridium and single-antigen test in the prior art is avoided. The antibody is pure, the valence is high, and the sensitivity and the accurate degree are improved. The single added Listeria bacterium is detected. Compared with an enzyme-linked immuno sorbent assay (ELISA) method and a PCR method, the reagent kit has the advantage that the Listeria bacterium detection is faster and more convenient by the immune colloidal gold chromatography.
Owner:何鑫 +4

Method and device for realizing COVID-19Ag antigen detection result identification based on vision, processor and storage medium thereof

PendingCN114742993AReduce the possibility of inaccuracyReduce manual review costsCharacter and pattern recognitionMedical imagesComputer hardwareMachine vision
The invention relates to a method for identifying and processing a COVID-19Ag antigen detection result based on machine vision. The method comprises the following steps: (1) identifying and acquiring an antigen detection kit body as a target detection object by mobile terminal equipment; (2) the mobile terminal device creates a target connection entity and carries out cloud uploading; (3) receiving a to-be-detected object by the cloud service, and performing target and result identification on the antigen detection kit through an AI target detection algorithm; (4) returning an identification detection result to the mobile terminal equipment in an array form; and (5) the mobile terminal device determines a final antigen detection result according to the returned array result. The invention further relates to a corresponding device, a processor and a computer readable storage medium thereof. By adopting the method and the device for realizing COVID-19Ag antigen detection result identification processing based on machine vision, the processor and the computer readable storage medium thereof, a large amount of manual checking cost can be efficiently and conveniently saved through batch automatic processing.
Owner:上海瞳熵科技有限公司

Chlamydia pneumoniae antigen detection plate and detection box

The invention provides a chlamydia pneumoniae antigen detection plate and a detection kit, the chlamydia pneumoniae antigen detection plate comprises an upper cover and a lower cover which are sealed and buckled, the upper cover is provided with a sample adding hole and an observation window, the lower cover is provided with a clamping groove, and a test strip is placed in the clamping groove, the chlamydia pneumoniae antigen detection plate is characterized in that the test strip comprises a PVC (polyvinyl chloride) batten, the PVC batten is provided with a nitrocellulose membrane, and the nitrocellulose membrane is connected with the upper cover. The position of the nitrocellulose membrane corresponds to the position of the observation window, absorbent paper is arranged at one end, far away from the sample adding hole, of the nitrocellulose membrane, a combination pad is arranged at the other end of the nitrocellulose membrane, the combination pad is completely covered by the upper cover, a sample adding pad is arranged at the free end of the combination pad, and the sample adding pad is arranged at the free end of the upper cover. The position of the sample adding hole corresponds to that of the sample adding pad; according to the invention, antigen detection is adopted, the antigen detection can be detected in an incubation period, an acute period or an initial disease course, and the antibody detection is later.
Owner:山东康华生物医疗科技股份有限公司

Antigen test kit suitable for self-service detection and data acquisition system

The invention discloses an antigen test kit suitable for self-service detection and a data acquisition system. A chromatography detection card of the antigen test kit is arranged in a test kit card shell; a serial number window, a result observation window and a sample adding opening are sequentially formed in the top surface of the test kit clamping shell upper cover; the sample pad and the water absorption pad are arranged at the two ends of the reaction pad, and the sample pad, the water absorption pad and the reaction pad are fixedly arranged between the test kit clamping shell upper cover and the test kit clamping shell bottom cover. And a background database of the antigen test data acquisition system stores a serial number of an antigen test kit, text information of a detection bar code and a corresponding detection result. The detection result is displayed in an encrypted pattern mode, the pattern or the decrypted text cannot be used for judging the detection result, the detection result can be obtained only by matching the pattern or the decrypted text with the serial number in a data acquisition system, detection is accurate and rapid, the device is simple and easy to popularize, and accurate and rapid centralized acquisition of the detection result can be achieved.
Owner:倪晟

Neutralizing epitope peptide in RBD region of SARS-CoV-2 S protein and application of neutralizing epitope peptide

On the basis of the neutralizing antibody in the RBD region of the SARS-CoV-2S protein, the Fab segment of the neutralizing antibody is prepared through recombinant expression, the Fab segment reacts with the RBD region of the SARS-CoV-2S protein to form an antigen-antibody compound, and purification, crystallization and X-crystal diffraction analysis are performed. The method comprises the following steps: analyzing an antigen-antibody compound structure by using a homologous compound three-dimensional structure in a PDB database as a model to obtain amino acid residues interacting with a neutralizing antibody on SARS-CoV-2S protein RBD, carrying out site-specific mutagenesis on key amino acid residues, and detecting the affinity of an SARS-CoV-2S protein RBD mutant and the neutralizing antibody Fab. And determining the epitope peptide fragment according to the influence degree of the RBD point mutation on the affinity. The invention also provides application of the epitope peptide fragment in preparation of a fusion antigen for detecting SARS-CoV-2, and application of the epitope peptide fragment in preparation of an immunogen for preparing a vaccine or an antibody.
Owner:MABWELL (SHANGHAI) BIOSCIENCE CO LTD

FRET-based homogeneous immunodetection method and detection composition

PendingCN114137217ALow background fluorescence interferenceHigh detection sensitivityBiological testingChemical physicsImmuno detection
The invention relates to an FRET (Fluorescence Resonance Energy Transfer)-based homogeneous immunodetection method and a detection composition, and belongs to the technical field of analytical chemistry. The technical problems that an existing FRET-based homogeneous immunodetection method is low in sensitivity, high in background fluorescence and the like are solved. The detection composition comprises a bismuth-based material marked with an antigen and a rare earth doped luminescent nanocrystal marked with an antibody, or the bismuth-based material marked with the antibody and the rare earth doped luminous nanocrystal marked with the antigen are included; wherein the antigen and the antibody are antigen-antibody pairs capable of carrying out specific binding reaction; the bismuth-based material is a bismuth-based two-dimensional nanosheet material or a metal ion doped bismuth-based two-dimensional nanosheet material. The invention also provides a method for antibody or antigen detection by using the detection composition. The FRET-based homogeneous immunodetection method has the advantages of small background fluorescence interference, high detection sensitivity, low cost, simplicity, convenience in operation and the like.
Owner:CHANGCHUN INST OF OPTICS FINE MECHANICS & PHYSICS CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products